8Rognas LK,Elkjaer P.Anaesthesia in day case laparoscopic femal sterlilzation:a comparison of two anaesthesic methods[J].Acta Anaesthesiol Scand,2004,48 (2):899-902.
二级参考文献33
1[1]Gepts E. Pharmacokinetics concepts for TCI anaesthesia[J]. Anaesthesia. 1998, 53: S4-12
2[2]Glen JB. Development of 'Diprifusor': a TCI system for propofol[J]. Anaesthesia, 1998, 53: S13-21
3[3]Glass PSA, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil[J]. Anesth Analg, 1999, 89: S7-14
4[4]Vuyk J, Mertens MJ, Olofsen E, et al. Propofol anesthesia and rational opioid selection[J]. Anesthesiology, 1997, 87: 1549-1562
5[5]Hoymork SC, Reder J, Grimsmo B, et al. Bispectral index, predicted and measured drug levels of target-controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergence[J]. Acta Anaesth Scand, 2000, 44: 1138-1144
6[6]Glass PSA, Shafer SL, Reves JG. Intravenous drug delivery system. In: Miller RD. Anesthesia[M].5th ed.USA: Churchill livingstone, 2001. 377-411
7[7]Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil[J]. Anesthesiology, 1997,86:10-23
8[8]Drover DR, Lemmens HJM. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery[J]. Anesthesiology, 1998,89:869-877
9[9]Lang E, Kaplia A, Shlugman D, et al. Reduction of isoflurane minimal alveolar concentration by remifentanil[J]. Anesthesiology, 1996,85:721-728
10[10]Coetzee JF, Glen JB, Wium CA, et al. Pharmacokinetics model selection for target controlled infusions of propofol: Assessment of three parameter sets[J]. Anesthesiology, 1995,82:1328-1345
